Senescence of Pre-Osteoclasts in Non-Traumatic OA
非创伤性骨关节炎中前破骨细胞的衰老
基本信息
- 批准号:10326804
- 负责人:
- 金额:$ 35.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-01-15 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAgeAgingAngiogenic FactorAnkleApoptosisAttenuatedBlood VesselsBone MarrowBone Marrow CellsBone TissueCartilageCell AgingCell Cycle ArrestCell ProliferationCellsChronicChronic DiseaseClinical ResearchDegenerative polyarthritisDeteriorationDevelopmentDiagnosticDiseaseElderlyEnrollmentFrail ElderlyFunctional disorderGenesGeneticGoalsHand OsteoarthritisHigh Fat DietHip OsteoarthritisHumanJointsKnee OsteoarthritisKnee jointMeasuresMechanicsMetabolicMetabolic syndromeMononuclearMusMusculoskeletal DiseasesObesityOsteoclastsOsteogenesisPathogenesisPathogenicityPatientsPharmacologyPhenotypePhysiologic OssificationPopulationPrevalenceReporterRisk FactorsRoleSkeletonSynovial MembraneTestingTissuesTransgenic OrganismsTubeVascular Endothelial CellWorkage relatedangiogenesisarthropathiesarticular cartilagebonebone cellcell typedefined contributiondriving forceepidemiology studyfrailtyfunctional lossgenetic approachjoint destructionjoint injurymetabolic phenotypemouse modelnovelosteoarthritis painoverexpressionplatelet-derived growth factor BBradiological imagingsenescencesubchondral bonetreatment strategy
项目摘要
SUMMARY/ABSTRACT
Osteoarthritis (OA) is the most prevalent age-associated chronic joint disease. Although direct joint injury and
excessive mechanical overloading are considered as important contributors to the development of OA, only
approximately 12% of the overall prevalence of symptomatic OA is attributable to posttraumatic OA of the hip,
knee, or ankle. Aging is recognized as the most important risk factor for OA, and the metabolic phenotype
becomes the second most frequent subtype of OA among patients enrolled in clinical studies. Recently, it has
been recognized that cellular senescence is a key driver for the progression of post-traumatic OA. However,
whether and how senescent cells (SnCs) are involved in the development of non-traumatic OA remain poorly
understood. In our preliminary study, we found accumulated SnCs at the joint subchondral bone marrow of both
spontaneous aging OA mice and STR/Ort mice, a spontaneous OA mice associated with metabolic dysregulation.
Increased SnCs were not detected in subchondral bone marrow of a post-traumatic OA mice. Therefore,
subchondral bone marrow cell senescence may represent a unique feature of non-traumatic subtype of OA
distinguishable from post-traumatic OA. Moreover, we identified that close to 80% of the SnCs are bone marrow
Pre-osteoclast (Pre-OC). Pre-OCs isolated from old mice, relative to young mice, had increased expression of
common senescence-associated secretory phenotype (SASP) factors and much higher expression of
angiogenesis factor PDGF-BB, a potent angiogenesis factor. It is known that increased subchondral bone
angiogenesis is a major contributor to the development of OA. Therefore, the excessive PDGF-BB secreted by
subchondral bone marrow SnCs may contribute to aberrant subchondral bone angiogenesis. Our central
hypothesis is that senescent Pre-OCs induce aberrant subchondral bone angiogenesis by secreting excessive
PDGF-BB, leading to OA-related joint structural damage. The hypothesis will be tested by the following Specific
Aims. In Aim 1, we will trace the SnCs in synovial tissue, articular cartilage, and subchondral bone tissue of the
joints by detecting the cellular senescence markers in spontaneous aging OA mice and STR/Ort mice. We will
also trace the SnCs at different stages of OC lineage and verify the SASP phenotype of the cells in bone marrow
of the mice. Aim 2 will examine the necessity and sufficiency of Pre-OCs-derived PDGF-BB in age-associated
subchondral bone angiogenesis and OA development. In Aim 3, we will first define the contribution of cellular
senescence to subchondral bone angiogenesis and osteogenesis by selectively eliminating the SnCs in OA mice.
We will then test if blockage of Pre-OC senescence using both genetic and pharmacologic approaches
attenuates OA progression.
总结/摘要
骨关节炎(OA)是最常见的与年龄相关的慢性关节疾病。虽然直接的关节损伤和
过度的机械超载被认为是OA发展的重要因素,只有
大约12%的症状性OA的总体患病率可归因于髋关节的创伤后OA,
膝盖或者脚踝衰老被认为是OA最重要的危险因素,代谢表型
成为临床研究中入组患者中第二常见的OA亚型。近日更
已经认识到细胞衰老是创伤后OA进展的关键驱动因素。然而,在这方面,
衰老细胞(SnCs)是否以及如何参与非创伤性OA的发展仍然不清楚,
明白在我们的初步研究中,我们发现在关节软骨下骨髓中积累的SnCs,
自发老化OA小鼠和STR/Ort小鼠,一种与代谢失调相关的自发OA小鼠。
在创伤后OA小鼠的软骨下骨髓中未检测到增加的SnCs。因此,我们认为,
软骨下骨髓细胞衰老可能是非创伤性OA亚型的独特特征
与创伤后OA不同。此外,我们发现,近80%的SnCs是骨髓
前破骨细胞(Pre-OC)。相对于年轻小鼠,从老年小鼠分离的前OC表达增加,
常见的衰老相关分泌表型(SASP)因子和高得多的
血管生成因子PDGF-BB是一种有效的血管生成因子。众所周知,增加的软骨下骨
血管生成是OA发展的主要因素。因此,过度的PDGF-BB分泌,
软骨下骨髓SnCs可能有助于异常的软骨下骨血管生成。我们的中央
假设衰老前OC通过分泌过量的
PDGF-BB,导致OA相关的关节结构损伤。该假设将通过以下具体测试进行检验:
目标。在目标1中,我们将追踪滑膜组织,关节软骨和软骨下骨组织中的SnCs。
通过检测自发老化OA小鼠和STR/Ort小鼠关节的细胞衰老标志物,我们将
并追踪OC不同阶段的SnCs,验证骨髓中细胞的SASP表型
的老鼠。目的2将检查Pre-OCs来源的PDGF-BB在年龄相关性中的必要性和充分性。
软骨下骨血管生成和OA发展。在目标3中,我们将首先定义细胞的贡献,
通过选择性消除OA小鼠中的SnCs来促进软骨下骨血管生成和成骨。
然后,我们将使用遗传学和药理学方法来测试是否阻断前OC衰老
减弱OA进展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mei Wan其他文献
Mei Wan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mei Wan', 18)}}的其他基金
Senescence of Pre-Osteoclasts in Non-Traumatic OA
非创伤性骨关节炎中前破骨细胞的衰老
- 批准号:
10090198 - 财政年份:2021
- 资助金额:
$ 35.23万 - 项目类别:
Identifying A Skeleton-Derived Factor for Vascular Aging
识别血管老化的骨骼衍生因子
- 批准号:
10544756 - 财政年份:2021
- 资助金额:
$ 35.23万 - 项目类别:
Identifying A Skeleton-Derived Factor for Vascular Aging
识别血管老化的骨骼衍生因子
- 批准号:
10380873 - 财政年份:2021
- 资助金额:
$ 35.23万 - 项目类别:
Identifying A Skeleton-Derived Factor for Vascular Aging
识别血管老化的骨骼衍生因子
- 批准号:
10202909 - 财政年份:2021
- 资助金额:
$ 35.23万 - 项目类别:
Senescence of Pre-Osteoclasts in Non-Traumatic OA
非创伤性骨关节炎中前破骨细胞的衰老
- 批准号:
10556420 - 财政年份:2021
- 资助金额:
$ 35.23万 - 项目类别:
Role of Cellular Senescence in the Bone-Brain Interplay
细胞衰老在骨脑相互作用中的作用
- 批准号:
10417206 - 财政年份:2020
- 资助金额:
$ 35.23万 - 项目类别:
Role of Cellular Senescence in the Bone-Brain Interplay
细胞衰老在骨脑相互作用中的作用
- 批准号:
10634546 - 财政年份:2020
- 资助金额:
$ 35.23万 - 项目类别:
Targeting aging genes and pathways to promote optic nerve regeneration
针对衰老基因和途径促进视神经再生
- 批准号:
10547815 - 财政年份:2020
- 资助金额:
$ 35.23万 - 项目类别:
Targeting aging genes and pathways to promote optic nerve regeneration
针对衰老基因和途径促进视神经再生
- 批准号:
10326837 - 财政年份:2020
- 资助金额:
$ 35.23万 - 项目类别:
Role of Cellular Senescence in the Bone-Brain Interplay
细胞衰老在骨脑相互作用中的作用
- 批准号:
10041954 - 财政年份:2020
- 资助金额:
$ 35.23万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 35.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 35.23万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 35.23万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 35.23万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 35.23万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 35.23万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 35.23万 - 项目类别:
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 35.23万 - 项目类别:
Operating Grants
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 35.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 35.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




